Clinical Trial Update: Bortezomib in Treating Patients With Malignant Pleural Mesothelioma [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating bortezomib in patients with malignant pleural mesothelioma; no efficacy results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Malignant Mesothelioma | Phase 2 | Status: COMPLETED